## HIG: The Hartford Insurance Group, I - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 1.41 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($130.61)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Water And Freezing Damage, Burglary Lead The Hartfordâ€™s Top Five Small-Business Claims**
- Source: Business Wire | 20251209T133232 | Bullish | Relevance: 99%
- The Hartford's analysis of small-business claims from 2020-2024 reveals that water and freezing damage are the most common, while fire claims are the most expensive. The company highlights the use of smart tools like water sensors and video cameras to help small businesses mitigate risks. The report also shows a rise in water damage claims over the last decade and the increasing cost of slip, fall, and customer injury claims due to litigation.

**2. State Street Corp Reduces Position in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251211T114856 | Somewhat-Bullish | Relevance: 98%
-  State Street Corp has reduced its stake in The Hartford Insurance Group, Inc. by 1.2%, selling over 193,000 shares. Despite this, other institutional investors have increased their holdings, and analysts maintain a "Moderate Buy" rating for HIG with a consensus target price of $143.50. The company recently increased its quarterly dividend to $0.60 per share.

**3. Hartford Financial Services stock price target raised to $155 by UBS**
- Source: Investing.com Canada | 20251209T030926 | Bullish | Relevance: 98%
-  UBS has increased its price target for Hartford Financial Services (NYSE:HIG) to $155.00 from $151.00, reiterating a Buy rating based on optimism following management meetings. The company shows strong financial health, diversified business segments, strategic investments in AI, and a solid dividend payment history, despite Goldman Sachs recently lowering its price target and revising EPS estimates due to a weaker business insurance loss ratio.

**4. The Hartford Insurance Group, Inc. $HIG Position Lifted by Bank of Nova Scotia**
- Source: MarketBeat | 20251210T100847 | Somewhat-Bullish | Relevance: 98%
-  Bank of Nova Scotia increased its stake in The Hartford Insurance Group (NYSE:HIG) by 40.4% in the second quarter, bringing its holdings to $14.86 million. Several other institutional investors also modified their positions in HIG, collectively owning 93.42% of the company's stock. Analysts have given the stock a consensus "Moderate Buy" rating with a target price of $143.50, and the company recently increased its quarterly dividend.

**5. The Hartford Insurance Group, Inc. $HIG Shares Purchased by Qube Research & Technologies Ltd**
- Source: MarketBeat | 20251211T120824 | Bullish | Relevance: 98%
-  Qube Research & Technologies Ltd significantly increased its stake in The Hartford Insurance Group, Inc. (NYSE:HIG) during the second quarter, now owning 0.30% of the company's stock valued at $105.6 million. This comes after The Hartford reported strong quarterly earnings, beating estimates, and raised its quarterly dividend to $0.60 per share. Other institutional investors have also adjusted their holdings, while an insider sold a significant number of shares in late October.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $155 | $151 | +3% |
| 2025-11-25 | Argus Research | $155 | $143 | +8% |
| 2025-11-17 | Morgan Stanley | $150 | $140 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Buy |
| 2025-11-25 | Argus Research | main | Buy |
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.96M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-0.8%)
- Blackrock Inc.: 10.9% (-4.4%)
- State Street Corpora: 5.8% (+0.3%)
- FMR, LLC: 4.9% (+13.2%)
- Price (T.Rowe) Assoc: 3.1% (-11.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +7.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.41 suggests fair value with growth premium. Quality metrics strong (ROE 20%). Balance sheet: strong liquidity (17.8x), $1.8B free cash flow. Analyst sentiment positive (3 raises, avg +6%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.0B |
| Beta | 0.63 |
| 52W Range | $104.93 - $138.64 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.41 |
| Forward P/E | 10.2 |
| Current P/E | 10.8 |
| YoY Growth | 5.2% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -5.6% to 1.6% (+7.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 3.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.55% (CS: 55) | Neutral |
| RSI_14 | 59.5 | Neutral |
| MACD Histogram | -0.50 | Bearish |
| vs SMA20 | 1.012x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.069x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $135.29
- **Stop Loss:** $130.61 (3.5% risk)
- **Target:** $139.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 294
- **Position Value:** $39,775.26
- **Portfolio %:** 39.78%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-29 (Est: $3.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.21 | $3.78 | +17.6% |
| 2025Q2 | $2.83 | $3.41 | +20.4% |
| 2025Q1 | $2.15 | $2.20 | +2.5% |
| 2024Q4 | $2.64 | $2.94 | +11.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*